Thoracic Cancer: Clinical Trials

5 trials for Thoracic Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 not yet recruiting. 5 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Recruiting 3, Not yet recruiting 2
Phase 13Recruiting 2, Not yet recruiting 1

Follow Thoracic Cancer: new trials by email Literature Review of Thoracic Cancer trials Research Report on Thoracic Cancer

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MINTER Trial: Metal Intervention aNd ThErapy With Radiotherapy In Thoracic Cancer Using Copper Donor Therapy: A Phase 2, Open-Label Study
Disulfiram 250 mg, Copper Gluconate 2 mg, Radiation Therapy - Thoracic Cancer
Phase 2Not yet recruitingM.D. Anderson Cancer Center302027-03-012026-09-28
TNG462-C103: Study to Evaluate the Safety, Tolerability, and Antitumor Activity of Vopimetostat in Combination With ERAS-0015 in PDAC and NSCLC Patients
vopimetostat, ERAS-0015 - PDAC, PDAC - Pancreatic Ductal Adenocarcinoma
Phase 1 / Phase 2Not yet recruitingTango Therapeutics, Inc.1882026-11-012026-10-27
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
Atorvastatin and Lisinopril, Placebo - Chest Wall Tumor, Breast Cancer
Phase 2RecruitingUNC Lineberger Comprehensive Cancer Center602026-08-122026-09-17
Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
PedmarkĀ® STS - Solid Tumor Malignancies, Testicular Cancer
Phase 1 / Phase 2RecruitingUniversity of Arizona252026-05-182026-06-18
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
TNG462, RMC-9805, RMC-6236 - PDAC, PDAC - Pancreatic Ductal Adenocarcinoma
Phase 1 / Phase 2RecruitingTango Therapeutics, Inc.1832025-05-312026-10-23

Narrower conditions

Lung Neoplasms (3)  ·  Breast Neoplasms (1)  ·  Cardiovascular Diseases (1)  ·  Esophageal Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Hearing Loss (1)  ·  Mediastinal Neoplasms (1)  ·  Neoplasms (1)  ·  Spinal Cord Neoplasms (1)  ·  Testicular Neoplasms (1)  ·  Thoracic Neoplasms (1)

Broader conditions

Neoplasms by Site (4)  ·  Lung Diseases (3)  ·  Neoplasms (3)  ·  Respiratory Tract Diseases (3)  ·  Respiratory Tract Neoplasms (3)  ·  Nervous System Diseases (2)  ·  Thoracic Neoplasms (2)  ·  Breast Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Neoplasms (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Ear Diseases (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)

Interventions

Atorvastatin (1)  ·  Disulfiram (1)  ·  Gluconates (1)  ·  Lisinopril (1)  ·  Radiotherapy (1)

Sponsors

Tango Therapeutics, Inc. (2)  ·  M.D. Anderson Cancer Center (1)  ·  UNC Lineberger Comprehensive Cancer Center (1)  ·  University of Arizona (1)

Countries

United States (4)

Top investigators

Alejandro Recio-Boiles, MD (1)  ·  Lisa Davis, PharmD (1)  ·  Maxim Pimpkin, MD, PhD (1)  ·  Shivani Sud, MD (1)  ·  Steven Lin, MD, PHD (1)